Physician profile
Krishna Modi
NPI 1841787108
$3,446.65
in general payments reported to CMS, 2019-2025
10 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.13 · 2023: $2,079 · 2024: $1,076 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,090 · Food and Beverage: $1,207 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,089.81 |
| Food and Beverage | $1,206.90 |
| Education | $135.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,078.66 | 2023 | Gallant, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $927.20 | 2024 | Impella |
| Medtronic, INC. | $133.68 | 2025 | Micra |
| Angiodynamics, INC. | $80.66 | 2024 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $67.84 | 2025 | |
| Novartis Pharmaceuticals Corporation | $53.50 | 2025 | |
| Amgen INC. | $36.93 | 2022-2025 | Repatha |
| Edwards Lifesciences Corporation | $34.56 | 2024 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $17.49 | 2024 | Avvigo Guidance System |
| Chiesi USA, INC. | $16.13 | 2024 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.